Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS

Area of Science:

• Hematology
• Oncology
• Transplantation Medicine

Background:

• Reduced-intensity conditioning (RIC) and non-myeloablative (NMA) regimens are alternatives to myeloablative (MA) conditioning in allogeneic hematopoietic cell transplantation.
• The comparative efficacy of MA, RIC, and NMA conditioning for acute myeloid leukemia (AML) and myelodysplasia (MDS) remains unclear.

Purpose of the Study:

• To compare the outcomes of MA, RIC, and NMA conditioning regimens in patients with AML and MDS undergoing allogeneic hematopoietic cell transplantation.
• To evaluate the impact of conditioning intensity on relapse, treatment-related mortality (TRM), disease-free survival (DFS), and overall survival (OS).

Main Methods:

• A retrospective analysis of 3731 MA and 1448 RIC/NMA procedures performed between 1997 and 2004 at 217 centers.
• Comparison of disease status, donor, graft, and recipient characteristics.
• Reporting of 5-year univariate probabilities and multivariate relative risk outcomes for relapse, TRM, DFS, and OS.

Main Results:

• Adjusted 5-year OS was 34% for MA, 33% for RIC, and 26% for NMA transplants.
• NMA conditioning was associated with inferior DFS and OS.
• No significant difference in DFS and OS was observed between RIC and MA regimens.
• Late TRM offset the early toxicity benefits of RIC and NMA regimens.

Conclusions:

• Higher conditioning regimen intensity may be associated with optimal survival in AML/MDS patients.
• Both regimen intensity and graft-versus-leukemia effect appear crucial in managing these diseases.
• Prospective studies are needed to directly compare MA and RIC/NMA regimens and establish the optimal conditioning approach.